KRAS and non-small cell lung carcinoma: Using a combination of genetically engineered mouse models, loss-of-function RNAi screens in primary tumor cells derived from these models, and 3D cultures of human non-small cell lung cancer cell lines we show that UHRF1 plays a key role in KRAS-driven oncogenesis.